STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1232 by analyst upside · 2026-08-13
NUTX
Nutex Health Inc.
Healthcare · Market Cap $1B · P/E 6.5x
ANALYST PRICE TARGET
+54.5%
implied upside to consensus target
Current Price $172.45
Consensus Target $266.4
Bull Target $310.0
Bear Target $200.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $77.21
52-Week High $204.0
YTD Return +16.4%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 6.5x
Forward P/E 8.5x
EPS (TTM) $26.73
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $847M
Profit Margin 21.2%
52-WEEK RANGE
52-Week Low $77.21
52-Week High $204.0
Current Price $172.45
Bear Target $200.0
Bull Target $310.0
● Now $172.45 ● Target $266.4
TRADING DATA
Avg Volume 137K
YTD Return +16.4%
Analyst Count 5
Consensus Buy
Upside to Target +54.5%
Last Updated 2026-08-13

ANALYST SUMMARY

Nutex Health Inc. (NUTX) is currently trading at $172.45 with a Wall Street consensus price target of $266.4, implying potential upside of 54.5% over the next 12 months. 5 analysts currently cover NUTX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $310.0, while the most cautious has a target of $200.0.

NUTX operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 16.4% year-to-date and is currently trading near the upper end of its 52-week range of $77.21 – $204.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NUTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Lake Street ● Initiated
Buy 2026-06-02 27% win rate (11 calls)
Maxim Group - Reiterated
Buy → Buy 2025-08-26 28% win rate (40 calls)
Benchmark reit
Buy → Buy 2025-07-10 Building track record
Maxim Group - Reiterated
Buy → Buy 2025-05-20 28% win rate (40 calls)
Benchmark - Reiterated
Buy → Buy 2025-05-15 Building track record
Benchmark - Reiterated
Buy → Buy 2025-04-09 Building track record
Maxim Group - Reiterated
Buy → Buy 2025-04-08 28% win rate (40 calls)
Maxim Group - Reiterated
Buy → Buy 2025-02-13 28% win rate (40 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
58
out of 100
Coverage depth
14/30
Consensus clarity
17/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →